Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement deposition at the neuromuscular junction in seronegative myasthenia gravis

10 Mar 2020

Abstract excerpt

Early active multiple sclerosis (MS) lesions can be classified histologically into three main immunopathological patterns of demyelination (patterns I-III), which suggest pathogenic heterogeneity and may predict therapy response. Patterns I and II show signs of immune-mediated demyelination, but only pattern II is associated with antibody/complement deposition. In pattern III lesions, which include Baló's...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Myasthenia Gravis and Thymoma
Share to Peripheral Neuropathies and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32157386
DOI: 10.1007/s00401-020-02147-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement deposition at the neuromuscular junction in seronegative myasthenia gravisPMID 32157386Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Pathophysiology, Clinical Patterns, and Therapeutic Challenges of Intractable and Severe FormsSemantic proximity Read ↗

Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disordersSemantic proximity Read ↗

Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSemantic proximity Read ↗

Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell DepletionSemantic proximity Read ↗

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).Semantic proximity Read ↗

mRNA Profiling of Inflammatory Stress Responses after Aquaporin-4 Antibody and Human Complement Treatment Reveals Upregulation of NF-κB and IL6 PathwaysSemantic proximity Read ↗

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Insights into pathogenesis and biomarkers of prognosisSemantic proximity Read ↗

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Semantic proximity Read ↗

Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseSemantic proximity Read ↗

NMO‐IgG: A Specific Biomarker for Neuromyelitis OpticaSemantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating DiseasesSemantic proximity Read ↗

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.